Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells

Biomedicine and Pharmacotherapy

Volumn 59, Issue SUPPL. 2, 2005, Pages

  Lev Ari, S ^a,b   Zinger, H ^a,b   Kazanov, D ^a   Yona, D ^a,b   Ben Yosef, R ^a,b   Starr, A ^a   Figer, A ^a   Arber, N ^a,b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Celecoxib; COX 2; Curcumin; Pancreatic cancer; Synergism

Indexed keywords

CELECOXIB; CURCUMIN; CYCLOOXYGENASE 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DIET; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; PANCREATIC NEOPLASMS; PYRAZOLES; SULFONAMIDES;

EID: 31544471349     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(05)80045-9     Document Type: Article

References (31)

1. Jemal A., Thomas A., Murray T., and Thun M. Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47
2. Burris H.A. III, Moore M.J., Andersen J., Green M.R., Rothenberg M.L., Modiano M.R., Cripps M.C., Portenoy R.K., Storniolo A.M., Tarassoff P., Nelson R., Dorr F.A., Stephens C.D., and Von Hoff D.D. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 1997 2403 2413
3. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871 1875
4. Myers L.K., Kang A.H., Postlethwaite A.E., Rosloniec E.F., Morham S.G., and Shlopov B.V. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis Arthritis Rheum 43 2000 2687 2693
5. Gupta R.A., and DuBois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nature Reviews Cancer 1 2001 11 21
6. Fournier D.B., and Gordon G.B. COX-2 and colon cancer: potential targets from chemoprevention J Cell Biochem Suppl 34 2000 97 102
7. Raut C.P., Nawrocki S., Lashinger L.M., Davis D.W., Khanbolooki S., Xiong H., Ellis L.M., and McConkey D.J. Celecoxib inhibits angiogenesis by inducing endothelial cell apoptosis in human pancreatic tumor xenografts Cancer Biol Ther 3 2004 1217 1224
8. Yip-Schneider M.T., Barnard D.S., Billings S.D., Cheng L., Heilman D.K., Lin A., Marshall S.J., Crowell P.L., Marshall M.S., and Sweeney C.J. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas Carcinogenesis 21 2000 139 146
9. Aggarwal S., Taneja N., Lin L., Orringer M.B., Rehemtulla A., and Beer D.G. Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome c independent of COX-2 expression Neoplasia 2 2000 346 356
10. Sheng H., Shao J., Washington M.K., and DuBois R.N. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells J Biol Chem 276 2001 18075 18081
11. Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis Cancer Metastasis Rev 19 2000 19 27
12. Dandekar D.S., and Lokeshwar B.L. Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs Clin Cancer Res 10 23 2004 Dec 1 8037 8047
13. Tsujii M., Kawano S., and DuBois R.N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential Proc Natl Acad Sci USA 94 1997 3336 3340
14. Achiwa H., Yatabe Y., Hida T., Kuroishi T., Kozaki K., Nakamura S., Ogawa M., Sugiura T., Mitsudomi T., and Takahashi T. Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas Clin Cancer Res 5 1999 1001 1005
15. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., and Whelton A. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study J Am Med Assoc 284 2000 1247 1255
16. 342 Janne P.A., and Mayer R.J. Chemoprevention of colorectal cancer N Engl J Med 29 26 2000 1960 1968
17. Solomon S.D., McMurray J.J., Pfeffer M.A., Wittes J., Fowler R., Finn P., Anderson W.F., Zauber A., Hawk E., Bertagnolli M., and Adenoma Prevention with Celecoxib (APC) Study Investigators Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 352 2005 1071 1080
18. Ammon H.P., and Wahl M.A. Pharmacology of Curcuma longa Planta Med 57 1991 1 7
19. Satoskar R.R., Shah S.J., and Shenoy S.G. Evaluation of anti-inflammatory property of curcumin (diferuloylmethane) in patients with postoperative inflammation Int J Clin Pharmacol Ther Toxicol 24 1986 651 654
20. Kawamori T., Lubet R., Steele V.E., Kelloff G.J., Kaskey R.B., and Rao C.V. Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer Cancer Res 59 3 1999 597 601
21. Goel A., Boland C.R., and Chauhan D.P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells Cancer Lett 172 2 2001 111 118
22. Zhang F., Altorki N.K., Mestre J.R., Subbaramaiah K., and Dannenberg A.J. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis 20 3 1999 445 451
23. Li L., Aggarwal B.B., Shishodia S., Abbruzzese J., and Kurzrock R. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis Cancer 101 10 2004 Nov 15 2351 2362
24. Starr A, Vexler A, Ashkenasi-Voghera M, Lev-Ari S, Konik D, Marmor S, Greif Y, Ben-Yosef R. Establishment and characterization of a pancreatic carcinoma cell line derived from a human metastatic pleural effusion. Oncology. In Press.
25. Arber N., Han E.K., Sgambato A., Piazza G.A., Delohery T.M., Begemann M., Weghorst C.M., Kim N.H., Pamukcu R., and Ahnen D.J. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes Gastroenterology 113 1997 1892 1900
26. Nov El-Rayes B.F., Ali S., Sarkar F.H., and Philip P.A. Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines Mol Cancer Ther 3 11 2004 1421 1426
27. Molina M.A., Sitja-Arnau M., Lemoine M.G., Frazier M.L., and Sinicrope F.A. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 17 1999 Sep 1 4356 4362
28. Perugini R.A., McDade T.P., Vittimberga F.J. Jr, Duffy A.J., and Callery M.P. Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines J Gastrointest Surg 4 2000 24 32
29. Kokawa A., Kondo H., Gotoda T., Ono H., Saito D., and Nakadaira S. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors Cancer 91 2001 333 338
30. Schernhammer E.S., Kang J.H., Chan A.T., Michaud D.S., Skinner H.G., and Giovannucci E. A prospective study of aspirin use and the risk of pancreatic cancer in women J Natl Cancer Inst 96 1 2004 Jan 7 22 28
31. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., and Shen T.S. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 4B 2001 2895 2900